PARRAVICINI, CHIARA
PARRAVICINI, CHIARA
Dipartimento di Scienze Farmacologiche e Biomolecolari
IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics
2022 S. Saporiti, C. Parravicini, C. Pergola, U. Guerrini, M. Rossi, F. Centola, I. Eberini
IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics
2022 S. Saporiti, C. Parravicini, C. Pergola, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease
2022 E. Ferrari, D. Scheggia, E. Zianni, M. Italia, M. Brumana, L. Palazzolo, C. Parravicini, A. Pilotto, A. Padovani, E. Marcello, I. Eberini, P. Calabresi, M. Diluca, F. Gardoni
Computational modelling of the LCAT::rHDL complex and bases of LCAT pharmacological activation
2021 T. Laurenzi, C. Parravicini, L. Palazzolo, U. Guerrini, L. Calabresi, I. Eberini
In silico investigations of N-glycosylation role in modulating IgG1 conformational behavior and Fc effector functions
2021 S. Saporiti, C. Parravicini, C. Pergola, U. Guerrini, M. Rossi, F. Centola, I. Eberini
Involvement of GPR17 in Neuronal Fibre Outgrowth
2021 M. Braune, N. Scherf, C. Heine, K. Sygnecka, T. Pillaiyar, C. Parravicini, B. Heimrich, M.P. Abbracchio, C.E. Müller, H. Franke
IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics
2021 S. Saporiti, C. Parravicini, C. Pergola, U. Guerrini, M. Rossi, F. Centola, I. Eberini
A novel SEMA3G mutation in two siblings affected by syndromic GnRH deficiency
2021 R. Oleari, V. Andrè, A. Lettieri, S. Tahir, L. Roth, A. Paganoni, I. Eberini, C. Parravicini, V. Scagliotti, L. Cotellessa, F. Bedogni, L.B. De Martini, M.V. Corridori, S. Gulli, H.G. Augustin, C. Gaston-Massuet, K. Hussain, A. Cariboni
Stress Modifies the Expression of Glucocorticoid-Responsive Genes by Acting at Epigenetic Levels in the Rat Prefrontal Cortex : Modulatory Activity of Lurasidone
2021 P. Brivio, G. Sbrini, L. Tarantini, C. Parravicini, P. Gruca, M. Lason, E. Litwa, C. Favero, M.A. Riva, I. Eberini, M. Papp, V. Bollati, F. Calabrese
rHDL modelling and the anchoring mechanism of LCAT activation
2020 T. Laurenzi, C. Parravicini, L. Palazzolo, U. Guerrini, E. Gianazza, L. Calabresi, I. Eberini
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination
2020 D. Capelli, C. Parravicini, G. Pochetti, R. Montanari, C. Temporini, M. Rabuffetti, M.L. Trincavelli, S. Daniele, M. Fumagalli, S. Saporiti, E. Bonfanti, M.P. Abbracchio, I. Eberini, S. Ceruti, E. Calleri, S. Capaldi
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis
2020 C. Parravicini, D. Lecca, D. Marangon, G.T. Coppolino, S. Daniele, E. Bonfanti, M. Fumagalli, L. Raveglia, C. Martini, E. Gianazza, M.L. Trincavelli, M.P. Abbracchio, I. Eberini
IgG1 Effecor functions: elucidation of glycans role by in silico structural analysis
2019 S. Saporiti, C. Parravicini, F. Centola, C. Pergola, I. Eberini
Mechanism of LAT1 amino acid antiporter: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor
2019 L. Palazzolo, C. Parravicini, T. Laurenzi, D. Polla, B. Guastella, U. Guerrini, C. Indiveri, E. Gianazza, I. Eberini
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach
2019 U. Guerrini, C. Parravicini, L. Palazzolo, E. Bonfanti, S. Raffaele, T. Laurenzi, M. Fumagalli, F. Di Renzo, R. Bacchetta, E. Menegola, I. Eberini
IgG1 effector functions: elucidation of glycans role by in silico structural analysis
2019 S. Saporiti, C. Parravicini, F. Centola, C. Pergola, I. Eberini
Purine nucleotides as potential ligands of G protein-coupled receptor 17 (GPR17)v: molecular modelling and synthesis
2019 M. Rabuffetti, C. Parravicini, S. Ceruti, T. Bavaro, E. Calleri, D. Ubiali, G. Speranza
Supramolecular modeling of an LCAT-rHDL assembly and cholesterol transesterification mechanism
2019 T. Laurenzi, C. Parravicini, L. Palazzolo, U. Guerrini, L. Calabresi, I. Eberini
N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases
2019 M. Abbracchio, M. Battaglia, I. Eberini, M. Fumagalli, C. Parravicini, C. Sensi, P. Zaratin
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor
2019 D. Polla, L. Palazzolo, C. Parravicini, T. Laurenzi, U. Guerrini, C. Indiveri, E. Gianazza, I. Eberini